[1] Stahl, S. M., Pradko, J. F., Haight, B. R., Modell, J. G., Rockett, C. B., & Learned-Coughlin, S. (2004). A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Primary care companion to the Journal of clinical psychiatry, 6(4), 159-166.
[2] Dwoskin, L. P., Rauhut, A. S., King‐Pospisil, K. A., & Bardo, M. T. (2006). Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Reviews, 12(3‐4), 178-207.
[3] Aubin, H. J., Luquiens, A., & Berlin, I. (2014). Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. British Journal of Clinical Pharmacology, 77(2), 324-336.
[4] Narinan B. M. (2008). United States Patent and Trademark Office.
[5] Bupropion Hydrochloride Monograph for Professionals. (2018). Drugs.com. American Society of Health-System Pharmacists.
[6] The Top 300 of 2020. (2020). Clinical tools and calculators for medical professionals.
[7] Bupropion˗Drug Usage Statistics. (2019). Clinical tools and calculators for medical professionals.
[8] Abbas, S. S., Elghobashy, M. R., Shokry, R. F., & Bebawy, L. I. (2012). Stability indicating HPLC and spectrophotometric methods for the determination of bupropion hydrochloride in the presence of its alkaline degradates and related impurity. Bulletin of Faculty of Pharmacy, Cairo University, 50(1), 49-59.
[9] El-Kosasy, A. M., Hussein, L. A., Salama, N. N., & Sedki, N. G. (2015). Kinetic study and peak purity determination of bupropion hydrochloride using RRLC/DAD and HPLC/MWD methods: stability study and application in pharmaceutical preparation and in synthetic mixtures with nicotine. RSC Advances, 5(79), 64274-64285.
[10] Castro-Puyana, M., García, M. Á., & Marina, M. L. (2008). Enantiomeric separation of bupropion enantiomers by electrokinetic chromatography: quantitative analysis in pharmaceutical formulations. Journal of Chromatography B, 875(1), 260-265.
[11] Masters, A. R., McCoy, M., Jones, D. R., & Desta, Z. (2016). Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion using HPLC–MS/MS. Journal of Chromatography B, 1015, 201-208.
[12] Wu, Q., Wang, C., Liu, Z., Wu, C., Zeng, X., Wen, J., & Wang, Z. (2009). Dispersive solid-phase extraction followed by dispersive liquid–liquid microextraction for the determination of some sulfonylurea herbicides in soil by high-performance liquid chromatography. Journal of Chromatography A, 1216(29), 5504-5510.
[13] Ghorbani, M., Aghamohammadhassan, M., Chamsaz, M., Akhlaghi, H., & Pedramrad, T. (2019). Dispersive solid phase microextraction. TrAC–Trends in Analytical Chemistry, 118, 793-809.
[14] Cha, C., Shin, S. R., Annabi, N., Dokmeci, M. R., & Khademhosseini, A. (2013). Carbon-based nanomaterials: multifunctional materials for biomedical engineering. ACS Nano, 7(4), 2891-2897.
[15] Sitko, R., Zawisza, B., & Malicka, E. (2013). Graphene as a new sorbent in analytical chemistry. TrAC–Trends in Analytical Chemistry, 51, 33-43.
[16] He, H., Klinowski, J., Forster, M., & Lerf, A. (1998). A new structural model for graphite oxide. Chemical Physics Letters, 287(1-2), 53-56.
[17] Mirzaei, N., Rezaei, V., & Aibaghi, B. (2019). Preconcentration and determination of diazepam in pharmaceutical and biological samples by graphene oxide based on dispersive solid phase microextraction. Journal of Applied Chemistry, 14(51), 21-34. (in persion)
[18] Ran, C., Chen, D., Ma, H., & Jiang, Y. (2017). Graphene oxide adsorbent based dispersive solid phase extraction coupled with multi-pretreatment clean-up for analysis of trace aflatoxins in traditional proprietary Chinese medicines. Journal of Chromatogrraphy B, 1044–1045, 120-126.
[19] Ebrahimi Askari, M., & Elhami, S. (2021). Synthesis and characterization of modified graphene oxide and its use for the removal of mercury (II) from aqueous samples. Journal of Applied Chemistry, 16(58), 245-256. (in persion)
[20] Li, N., Chen, J., & Shi, Y. P. (2019). Magnetic nitrogen-doped reduced graphene oxide as a novel magnetic solid-phase extraction adsorbent for the separation of bisphenol endocrine disruptors in carbonated beverages. Talanta, 201, 194-203.
[21] Hassanzadeh, A., Ghorbani Kalhor, E., Farhadi, K., & Abolhasani, J. Feasibility Study of Using graphene Oxide/silica Gel Nanocomposite Prepared by Sol-gel Method for Removing Malachite Green from Aqueous Solutions: Optimization, Kinetic, and Isotherm Studies (2021). Analytical and Bioanalytical Chemistry Research, 9(2), 141-145.
[22] Sheibani, A., & Haghpazir, N. (2014). Application of ion mobility spectrometry for the determination of tramadol in biological samples. Journal of Food Drug Analysis, 22(4), 500-504.
[23] Crawford, C., & Hill Jr, H. (2013). Evaluation of false positive responses by mass spectrometry and ion mobility spectrometry for the detection of trace explosives in complex samples. Analytical Chimica Acta, 795, 36-43.
[24] Cumeras, R., Figueras, E., Davis, C., Baumbach, J. I., & Gracia, I. (2015). Review on ion mobility spectrometry. Part 1: current instrumentation. Analyst, 140(5), 1376-1390.
[25] Thoben, C., Raddatz, C.-R., Lippmann, M., Salehimoghaddam, Z., & Zimmermann, S. (2021). Electrospray ionization ion mobility spectrometer with new tristate ion gating for improved sensitivity for compounds with lower ion mobility. Talanta, 233, 122579.
[26] Liao, S., & Liang, X. (2020). Rapid measurement of Phthalic acid Ester environmental hormones using ion mobility spectrometry. International Journal for Ion Mobility Spectrometry, 23(2), 97-103.
[27] Han, Q., Wang, Z., Xia, J., Chen, S., Zhang, X., & Ding, M. (2012). Facile and tunable fabrication of Fe3O4/graphene oxide nanocomposites and their application in the magnetic solid-phase extraction of polycyclic aromatic hydrocarbons from environmental water samples. Talanta, 101, 388-395.
[28] Valadbeigi, Y., Ilbeigi, V., Afgar, A., & Soleimani, M. (2021). Comparison of the positive and negative modes of corona discharge ion source for direct determination of aspirin in urine by ion mobility spectrometry. International Journal of Mass Spectrometry, 470, 116699.
[29] Khalesi, M., Sheikh-Zeinoddin, M., & Tabrizchi, M. (2011). Determination of ochratoxin A in licorice root using inverse ion mobility spectrometry. Talanta, 83(3), 988-993.
[30] Fu, R., & Zhu, M. (2016). Synthesis and characterization of structure of Fe3O4@ graphene oxide nanocomposites. Advanced Composites Letters, 25(6), 143-146.
[31] Li, C., Wei, R., Xu, Y., Sun, A., & Wei, L. (2014). Synthesis of hexagonal and triangular Fe3O4 nanosheets via seed-mediated solvothermal growth. Nano Research, 7, 536-543.
[32] Abdel-Gawad, S. A., & El-Gamal, R. M. (2018). Simultaneous determination of naltrexone and bupropion in their co-formulated tablet utilizing green chromatographic approach with application to human urine. Saudi Pharmaceutical Journal, 26(2), 169-176.
[33] Loboz, K. K., Gross, A. S., Ray, J., & McLachlan, A. J. (2005). HPLC assay for bupropion and its major metabolites in human plasma. Journal of Chromatography B, 823(2), 115-121.
)